- Equillium to Present at Leerink Partners Global Healthcare Conference
- Cytokinetics Reports Fourth Quarter 2018 Financial Results
- Catalyst Pharmaceuticals Responds to Letter from Senator Bernie Sanders
- Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
- RedHill Biopharma to Host Full-Year 2018 Financial Results Conference Call on February 26, 2019
- Dermavant Sciences to Present Data on Tapinarof for Psoriasis and Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting
- CCAB announces creation of new brain cancer therapeutic company, Empirica Therapeutics, as part of its strategy to advance new early-stage life sciences companies
- Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator
- CannabisNewsAudio Announces Audio Press Release (APR) on Youngevity International, Inc. Employing All-Under-One-Roof Strategy Through CBD Investment
- Uptick Newswire Hosts Premier Biomedical, Inc. on The Stock Day Podcast to Discuss the Company’s Current Projects
